Journalartikel

Jahr der Veröffentlichung: 2018

Seiten: 79-92

Zeitschrift: Urologe A

Bandnummer: 57

Heftnummer: 1

ISSN: 0340-2592

eISSN: 1433-0563

DOI Link: https://doi.org/10.1007/s00120-017-0559-1

Verlag: Springer

Abstract: 
Urosepsis is defined as a severe disease due to organ failure caused by a urinary tract infection. An empirical antibiotic therapy should be instigated within the first hour after diagnosis. Urine cultures and blood cultures should be performed before antibiotic treatment. Further diagnostics should be carried out at an early stage to enable an interventional focus control in the case of urinary tract obstruction or abscess formation, if necessary. Gram-negative pathogens are most frequently isolated. Extended spectrum beta-lactamase (ESBL) forming bacteria as a cause of urosepsis are increasing. Carbapenemase-forming Enterobacteriaceae, on the other hand, are still rare. The empirical treatment consists of a broad spectrum beta-lactam antibiotic. While piperacillin/tazobactam, carbapenems and the new cephalosporin/beta-lactamase inhibitor (BLI) combinations are given as monotherapy, cephalosporins should be combined with aminoglycosides (preferred) or fluoroquinolones. If a combination therapy is given, it should be de-escalated to a monotherapy after 48-72 h.

Harvard-Zitierstil: Pletz, M., Weis, S., Forstner, C. and Wagenlehner, F. (2018) Urosepsis, Urologe A, 57(1), pp. 79-92. https://doi.org/10.1007/s00120-017-0559-1

APA-Zitierstil: Pletz, M., Weis, S., Forstner, C., & Wagenlehner, F. (2018). Urosepsis. Urologe A. 57(1), 79-92. https://doi.org/10.1007/s00120-017-0559-1